Association between statin-use and mobility and long-term survival after major lower limb amputation.

IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE
Vascular Pub Date : 2024-12-01 Epub Date: 2023-07-31 DOI:10.1177/17085381231192724
Arsalan Wafi, Vijay Kolli, Luis Ribeiro, Bilal Azhar, James Budge, Shreya Chawla, Paul Moxey, Ian M Loftus, Peter J E Holt
{"title":"Association between statin-use and mobility and long-term survival after major lower limb amputation.","authors":"Arsalan Wafi, Vijay Kolli, Luis Ribeiro, Bilal Azhar, James Budge, Shreya Chawla, Paul Moxey, Ian M Loftus, Peter J E Holt","doi":"10.1177/17085381231192724","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to determine if there is an association between statin-use and prosthetic mobility and long-term survival in patients receiving rehabilitation after major amputation for lower limb arterial disease.</p><p><strong>Methods: </strong>A retrospective analysis of prospectively maintained data (2008-2020) from a centre for rehabilitation was performed. Patients were grouped by statin-use status and sub-grouped by the combination of statin and antithrombotic drugs (antiplatelets or anticoagulants). Outcomes were prosthetic mobility (SIGAM score, timed-up-go and 2-min walking distance) and long-term survival. Regression, Kaplan-Meier and Cox-proportional hazard analyses were performed to test associations adjusted to confounders.</p><p><strong>Results: </strong>Of 771 patients, 499 (64.7%) were on a statin before amputation or prescribed a statin peri-operatively. Rate of statin-use was significantly lower among female (53.3%) compared to male (68.2%) patients, <i>P</i> < 0.001. Statin-use was associated with significantly better prosthetic independence (53.1% vs 44.1%, <i>P</i> = 0.017), timed-up-go (mean difference of 4 s, <i>P</i> = 0.04) and long-term survival HR 0.59 (0.48-0.72, <i>P</i> < 0.001). Significance persisted after adjusting for confounding factors and in subgroup analyses. The combination of statin with antiplatelet was associated with the most superior survival, HR 0.51 (0.40-0.65, <i>P</i> < 0.001). Sensitivity analysis (exclusion of non-users of prosthesis) showed that statin-use remained a significant indicator of longer survival, maximally when combined with antiplatelet use HR 0.52 (0.39-0.68, <i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>Statin-use is associated with better mobility and long-term survival in rehabilitees after limb loss, particularly when used in combination with antiplatelets. Significantly lower rates of statin-use were observed in female patients. Further research is warranted on gender disparities in statin-use and causality in their association with improved mobility and survival.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"1240-1249"},"PeriodicalIF":1.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17085381231192724","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The aim of this study was to determine if there is an association between statin-use and prosthetic mobility and long-term survival in patients receiving rehabilitation after major amputation for lower limb arterial disease.

Methods: A retrospective analysis of prospectively maintained data (2008-2020) from a centre for rehabilitation was performed. Patients were grouped by statin-use status and sub-grouped by the combination of statin and antithrombotic drugs (antiplatelets or anticoagulants). Outcomes were prosthetic mobility (SIGAM score, timed-up-go and 2-min walking distance) and long-term survival. Regression, Kaplan-Meier and Cox-proportional hazard analyses were performed to test associations adjusted to confounders.

Results: Of 771 patients, 499 (64.7%) were on a statin before amputation or prescribed a statin peri-operatively. Rate of statin-use was significantly lower among female (53.3%) compared to male (68.2%) patients, P < 0.001. Statin-use was associated with significantly better prosthetic independence (53.1% vs 44.1%, P = 0.017), timed-up-go (mean difference of 4 s, P = 0.04) and long-term survival HR 0.59 (0.48-0.72, P < 0.001). Significance persisted after adjusting for confounding factors and in subgroup analyses. The combination of statin with antiplatelet was associated with the most superior survival, HR 0.51 (0.40-0.65, P < 0.001). Sensitivity analysis (exclusion of non-users of prosthesis) showed that statin-use remained a significant indicator of longer survival, maximally when combined with antiplatelet use HR 0.52 (0.39-0.68, P < 0.001).

Conclusions: Statin-use is associated with better mobility and long-term survival in rehabilitees after limb loss, particularly when used in combination with antiplatelets. Significantly lower rates of statin-use were observed in female patients. Further research is warranted on gender disparities in statin-use and causality in their association with improved mobility and survival.

他汀类药物的使用与下肢大截肢后的活动能力和长期存活率之间的关系。
目的:本研究旨在确定他汀类药物的使用与下肢动脉疾病大截肢后接受康复治疗的患者的假肢活动能力和长期存活率之间是否存在关联:对一家康复中心的前瞻性数据(2008-2020年)进行了回顾性分析。根据他汀类药物的使用情况对患者进行分组,并根据他汀类药物和抗血栓药物(抗血小板或抗凝剂)的组合情况对患者进行分组。研究结果包括假肢活动度(SIGAM评分、定时起立行走和2分钟步行距离)和长期存活率。通过回归分析、Kaplan-Meier分析和Cox比例危险分析来检验与混杂因素的关联:在771名患者中,有499人(64.7%)在截肢前服用过他汀类药物,或在围手术期服用过他汀类药物。与男性患者(68.2%)相比,女性患者(53.3%)使用他汀类药物的比例明显较低,P < 0.001。他汀类药物的使用与假体独立性(53.1% vs 44.1%,P = 0.017)、定时起立(平均差异为 4 秒,P = 0.04)和长期存活率 HR 0.59(0.48-0.72,P < 0.001)显著提高相关。在调整混杂因素和进行亚组分析后,显著性依然存在。他汀类药物与抗血小板药物联合使用的生存率最高,HR 为 0.51(0.40-0.65,P < 0.001)。敏感性分析(排除未使用假体者)显示,他汀类药物的使用仍是延长生存期的重要指标,与抗血小板药物联合使用时的最大生存率为HR 0.52(0.39-0.68,P < 0.001):他汀类药物的使用与肢体缺失康复者更好的活动能力和长期存活率有关,尤其是与抗血小板药物联合使用时。女性患者使用他汀类药物的比例明显较低。关于他汀类药物使用中的性别差异及其与改善活动能力和存活率之间的因果关系,还有待进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vascular
Vascular 医学-外周血管病
CiteScore
2.30
自引率
9.10%
发文量
196
审稿时长
6-12 weeks
期刊介绍: Vascular provides readers with new and unusual up-to-date articles and case reports focusing on vascular and endovascular topics. It is a highly international forum for the discussion and debate of all aspects of this distinct surgical specialty. It also features opinion pieces, literature reviews and controversial issues presented from various points of view.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信